TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
4 hedge funds and large institutions have $11K invested in Therapix Biosciences Ltd. in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
| 1 |
ARTA
A.R.T. Advisors
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $5K | +$4.35K | +10,030 | +667% |
|
|
2
Citadel Advisors
Miami,
Florida
| $4K | +$4K | +10,180 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | +$1.31K | +3,576 | +189% |
|
|
ARTA
4
A.R.T. Advisors
New York
| – | -$15K | -13,504 | Closed |
|